Therapeutics clinic

SGLT-2 inhibitors: the gift that keeps on giving

Dimity L. Williams, Serena Rafail, John J. Atherton

Sodium-glucose cotransporter-2 inhibitors should be considered in the early management of patients who have chronic heart failure and chronic kidney disease, with or without diabetes.